Vitamin B12 — Research Evidence

The body of evidence on Vitamin B12 spans multiple study types, including meta-analyses, systematic reviews, and randomized controlled trials (RCTs), making it one of the better-studied B vitamins. The research consistently supports B12's fundamental role in neurological function, red blood cell production, and DNA synthesis. Deficiency is well-documented as a cause of peripheral neuropathy, cognitive decline, and psychiatric symptoms including depression and fatigue. Populations at elevated risk — including older adults, vegetarians and vegans, metformin users, and breastfeeding mothers — are consistently identified across multiple reviews as warranting particular attention. Across the retrieved literature, a meta-analysis and systematic reviews provide moderate-to-strong support for the idea that B12 supplementation can improve cognitive function in individuals with deficiency or impairment, reduce depressive symptoms, and alleviate fatigue. An RCT on diabetic neuropathy and another on cognitive impairment suggest clinically meaningful benefits in targeted populations. A network meta-analysis examined different supplementation routes (oral vs. intramuscular, etc.), indicating that route of administration matters for treatment outcomes. Vegan and vegetarian populations receive dedicated attention in several reviews, with consistent findings that plant-based diets carry high B12 deficiency risk due to near-absence of B12 in plant foods. B12's role in myelin synthesis — the fatty insulating sheath around nerve fibers — is treated as an established biochemical fact across multiple sources, with deficiency linked to demyelination and subacute combined degeneration of the spinal cord. Several important caveats apply. The majority of retrieved articles are reviews rather than primary trials, and the RCTs included are moderate rather than high quality, with limitations around sample size, population specificity, and duration. Importantly, the meta-analysis and systematic reviews lack reported sample sizes and specific key findings in the data provided, limiting precise quantitative conclusions. Most benefit evidence is strongest in people who are already deficient — it remains unclear whether supplementation meaningfully benefits individuals with normal B12 status. Diagnostic thresholds for deficiency are debated, and the evidence supports using both serum B12 and homocysteine levels together rather than relying on either alone. The psychiatric and cognitive symptom data, while partially supported, involves complex causality and confounding factors that are difficult to isolate. Specific populations such as young children on vegan diets and breastfeeding mothers are flagged as high-priority but remain understudied in rigorous intervention trials.

Studies (21)